Dr. Irene Morae Kang, MD
- Medicare services, 2024
- 320
- Medicare patients, 2024
- 168
- Part D claims, 2024
- 367
- Publications
- 17
- Clinical trials
- 1
- Practice address
- 1000 Fivepoint, Irvine, CA 92618
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
City of Hope National Medical Cente - City of Hope Lennar Oncology/Infusion - HOPD
Acute Care Hospital outpatient department · Irvine, California
Find Dr. Kang's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Irene Morae Kang is a medical oncologist in Irvine, California
Dr. Kang practices at City of Hope National Medical Cente - City of Hope Lennar Oncology/Infusion - HOPD in Irvine, California.
Dr. Kang's NPI, 1336430727, was assigned on April 20, 2011. Dr. Kang graduated from UCSF School of Medicine in 2011. Dr. Kang holds California license A124670.
- NPI
- 1336430727NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9739468331
- NPI enumeration date
- April 20, 2011
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 41
- Medical school graduation
- 2011
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Irene Morae Kang practices at City of Hope National Medical Cente - City of Hope Lennar Oncology/Infusion - HOPD in Irvine, California
Dr. Kang's primary practice is City of Hope National Medical Cente - City of Hope Lennar Oncology/Infusion - HOPD, at 1000 Fivepoint, Irvine, CA 92618.
- City of Hope National Medical Cente - City of Hope Lennar Oncology/Infusion - HOPD1000 Fivepoint, Irvine, CA 92618
Source: Dmand AI Affiliation Data
Dr. Irene Morae Kang is affiliated with 4 sites of care and 2 medical groups
Dr. Kang's primary practice is City of Hope National Medical Cente - City of Hope Lennar Oncology/Infusion - HOPD in Irvine, California. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Kang to 2 more group practices and clinics, 1 other site and 1 medical group, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Irene Morae Kang's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kang practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| City of Hope National Medical Cente - City of Hope Lennar Oncology/Infusion - HOPD | Available with a free account |
| +3 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Irene Morae Kang is one of 415 medical oncologists in California
Medical oncology is Dr. Kang's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kang is board certified in hematology by the American Board of Internal Medicine. Dr. Kang is licensed in California.
Specialties and state licenses
- Medical oncology, CaliforniaPrimary
Clinical focus
Dmand AI lists breast cancer, chronic anemia, chronic leukemia, fluid and electrolyte imbalances, lung cancer, lymphedema and prostate cancer among the conditions Dr. Kang treats.
Medical oncologists near Dr. Kang
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Irene Morae Kang billed Medicare for 320 services in 2024
CMS data shows 320 Medicare services from Dr. Kang across 4 procedure codes in 2024, for 168 Medicare patients. Medicare paid $35,749 for them. Every service was in an office.
Dr. Kang's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3672024: 30916%
- Other services
- 2023: 02024: 11
Dr. Kang compared with the California median for medical oncologists, 2024
- Dr. Kang
- California median
- Medicare services
- 320vs 49635% below
- Medicare patients
- 168vs 1549% above
- Part D claims
- 238vs 14465% above
Medians across 358 medical oncologists in California with Dmand AI profiles that report each measure.
Dr. Kang's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kang?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kang and other medical oncologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Irene Morae Kang treated 168 Medicare patients in 2024, average age 71
CMS counts 168 Medicare patients who saw Dr. Kang in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have cancer, and 68% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Kang's median patient age at 66, with 97% women.
Dr. Kang's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Kang's Medicare patients, 2024
- Cancer75%
- High cholesterol68%
- High blood pressure55%
- Arthritis45%
- Osteoporosis40%
- Anxiety29%
- Diabetes24%
- Mood disorders21%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kang's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women97%
- Men2%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Irene Morae Kang wrote 367 Medicare Part D claims in 2024
In 2024, Dr. Kang wrote 367 Medicare Part D claims for 101 patients. 76% of them were for generic drugs. CMS names the drug for 238 of them, across 8 drugs with 11 or more claims each, at $670,490 in total drug cost. In 2023, CMS named 318 claims across 11 drugs.
Dr. Kang's Part D claims by kind of drug, 2024
- Generic279 claims76%
- Brand-name and other88 claims24%
Dr. Kang's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3182024: 23825%
Drugs named by CMS: 8 in 2024, 11 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Irene Morae Kang offers telehealth to Medicare patients
Dr. Kang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kang as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Irene Morae Kang has 17 publications on record
Dmand AI links 17 papers to Dr. Kang, published from 2007 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, DNA Copy Number Variations and Cell Line, Tumor. Dr. Kang has published most often in Int J Mol Sci. Dr. Kang's most frequent co-authors are Julie E. Lang, MD, George Willard Sledge, MD and Karam Ashouri, MD.
Dr. Kang's papers by year, 2007 to 2025
Topics Dr. Kang writes about most
- Breast Neoplasms
- DNA Copy Number Variations
- Cell Line, Tumor
- Ethnicity
- Exome Sequencing
- Gene Expression Regulation, Neoplastic
- Neoplasm Metastasis
- Neoplastic Cells, Circulating
Dr. Kang's most frequent co-authors
- Julie E. Lang, MD4 shared papers
- George Willard Sledge, MD2 shared papers
- Karam Ashouri, MD1 shared paper
Recent publications by Dr. Kang
JCO Precis Oncol
Int J Mol Sci
See who Dr. Kang researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kang works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Irene Morae Kang has worked on 1 clinical trial
Dmand AI links Dr. Kang to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.
Conditions in Dr. Kang's trials
- Breast Neoplasms
- Breast Diseases
Recent clinical trials with Dr. Kang
Trial of BDC-1001 +/- Pertuzumab in Subjects with HER2-Positive Metastatic Breast Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Irene Morae Kang received $69,073 in industry payments from 2016 to 2025
CMS Open Payments shows 190 general payments to Dr. Kang from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Puma Biotechnology, Inc. paid the most, $23,856.
General payments to Dr. Kang by program year, 2016 to 2025
General payments to Dr. Kang by kind, 2016 to 2025
- Consulting fees$46,73368%
- Speaker and faculty fees$13,22019%
- Food and beverage$5,6248%
- Travel and lodging$3,2445%
- Education$2530%
Companies that paid Dr. Kang the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Irene Morae Kang graduated from UCSF School of Medicine
Dr. Kang graduated from UCSF School of Medicine in 2011.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Irene Morae Kang accepts plans from 11 insurance carriers
Dr. Kang is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.
- Aetna
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Elevance
- Blue Cross Blue Shield of Massachusetts
- HCSC
- Regence Health Plans
- Alliant Health Plans
- +3 more carriersWith a free account
Plan types Dr. Kang accepts, by number of carriers
- Medicare8
- PPO8
- HMO5
- EPO2
- POS2
Source: Dmand AI Insurance Network Data
Sources for Dr. Irene Morae Kang's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Irene Morae Kang
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Irene Morae Kang's NPI number?
Dr. Irene Morae Kang's NPI number is 1336430727. It was assigned on April 20, 2011, and it is active in the NPI Registry.
What kind of doctor is Dr. Irene Morae Kang?
Dr. Irene Morae Kang is a medical oncologist in Irvine, California. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Irene Morae Kang practice?
Dr. Kang practices at 1000 Fivepoint, Irvine, CA 92618. Dr. Kang's primary practice is City of Hope National Medical Cente - City of Hope Lennar Oncology/Infusion - HOPD in Irvine, California. Dmand AI also links Dr. Kang to 2 group practices and clinics, 1 other site and 1 medical group.
What is Dr. Irene Morae Kang's medical license number?
Dr. Kang holds California license A124670.
What medical group is Dr. Irene Morae Kang part of?
Dr. Kang is linked to USC Care Medical Group. Dmand AI links Dr. Kang to 1 more medical group.
Does Dr. Irene Morae Kang accept Medicare?
Yes. CMS data shows Dr. Kang billed Medicare for 320 services in 2024, and Dr. Kang accepts Medicare assignment.
Does Dr. Irene Morae Kang offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Kang as offering telehealth services.
How many Medicare patients does Dr. Irene Morae Kang see?
CMS counts 168 Medicare patients who saw Dr. Kang in 2024, with an average age of 71.
Is Dr. Irene Morae Kang board certified?
Yes. Dr. Kang is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Irene Morae Kang bill to Medicare?
In 2024, Dr. Kang's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and office visit, new patient (99205).
Show 7 more questionsShow fewer questions
Where did Dr. Irene Morae Kang go to medical school?
Dr. Kang graduated from UCSF School of Medicine in 2011.
What drugs does Dr. Irene Morae Kang prescribe most?
In 2024 Medicare Part D data, Dr. Kang's most prescribed drugs by claims were Letrozole, Anastrozole and Exemestane.
Has Dr. Irene Morae Kang received payments from drug or device companies?
CMS Open Payments shows $69,073 in general payments to Dr. Kang from 24 companies from 2016 to 2025. The largest total came from Puma Biotechnology, Inc.
How long has Dr. Irene Morae Kang been practicing?
Dr. Kang graduated from medical school in 2011, 15 years ago.
Does Dr. Irene Morae Kang do research?
Dmand AI links 17 publications to Dr. Kang, published from 2007 to 2025. Dr. Kang has worked on 1 clinical trial.
Who does Dr. Irene Morae Kang publish with?
Dr. Kang's most frequent co-authors are Julie E. Lang, MD (4 shared papers), George Willard Sledge, MD (2 shared papers) and Karam Ashouri, MD (1 shared paper).
What insurance does Dr. Irene Morae Kang accept?
Dr. Kang is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card